Trial intelligence / Profile preview

Risperidone versus haloperidol versus placebo for delirium in palliative care

ACTRN12607000562471Phase 3Completed

Sponsor
Flinders University
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in delirium comparing Oral risperidone, Oral haloperidol and Placebo syrup (3 arms). Primary endpoint: Target symptom score on Nursing Delirium Screening Scale. Started Aug 2008; status: completed.

02

Drugs

risperidonehaloperidol
03

Conditions

delirium

Beyond the preview

Go deeper on ACTRN12607000562471.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12607000562471.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call